Literature DB >> 31646292

Association between thyroid abnormalities and hypertension among hospitalized US patients: data from the National Inpatient Sample.

Sijan Basnet1, Rashmi Dhital1, Biswaraj Tharu2, Sushil Ghimire1, Dilli R Poudel1.   

Abstract

Abnormalities of thyroid, namely hyperthyroidism and hypothyroidism, are both associated with increased risk of hypertension. We utilized the National Inpatient Sample from the years 2012-2014 to explore the risk of thyroid disorders in relation to those without a thyroid diagnosis. We found that hypertension was more commonly associated with hyperthyroidism (odds ratio: 1.18; 95% confidence interval: 1.16-1.21, P<0.0001) than with hypothyroidism (odds ratio: 1.06; 95% confidence interval: 1.06-1.07, P<0.0001) when both were compared with hypertension without a thyroid diagnosis.
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Keywords:  National Inpatient Sample; hypertension; hyperthyroidism; hypothyroidism

Year:  2018        PMID: 31646292      PMCID: PMC6739853          DOI: 10.1097/XCE.0000000000000155

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


  4 in total

Review 1.  Hypertension and hypothyroidism.

Authors:  A K Fletcher; A P Weetman
Journal:  J Hum Hypertens       Date:  1998-02       Impact factor: 3.012

2.  Masked hypertension in newly diagnosed hypothyroidism: a pilot study.

Authors:  E Piantanida; D Gallo; G Veronesi; N Pariani; E Masiello; P Premoli; L Sassi; A Lai; M L Tanda; M Ferrario; L Bartalena
Journal:  J Endocrinol Invest       Date:  2016-05-19       Impact factor: 4.256

Review 3.  Hyperthyroidism: a secondary cause of isolated systolic hypertension.

Authors:  L Michael Prisant; Jaspal S Gujral; Anthony L Mulloy
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-08       Impact factor: 3.738

4.  Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology.

Authors:  Sibel Ertek; Arrigo F Cicero
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.